Dengue Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (NSAIDS, Antibiotics, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Region

Dengue Treatment Market size was valued at US$ 324.3 million in 2022 and is growing at a CAGR of 13.6% from 2023 to 2029. The global market provides a detailed overview that can be segmented by drug class and by distribution channel. By drug class, the global dengue treatment market has been segmented into NSAIDS, Antibiotics, and Corticosteroids. The NSAIDs dengue treatment segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. Based on the distribution channel, the segment has been segregated into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Hospital pharmacies segment is expected to dominate other segments in the global dengue treatment market. The retail pharmacies segment is expected to witness the highest CAGR during the forecast period according to precision business insights. Dengue fever also known as break bone fever is a mosquito-born and endemic disease that leads to severe flu-like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several species of mosquitos of the Aedes type, principally Aegypti. Symptoms of dengue include fever, headache vomiting, muscle and joint pains, and characteristic skin rash. On infection of dengue, a patient will automatically recover within seven days. But in some cases, it may develop into life-threatening dengue hemorrhagic fever. The virus has five different types of strains, infection with one strain usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.